Voice Acoustic Properties in People With Obstructive Sleep Apnea Syndrome (OSAS)

NCT ID: NCT03568240

Last Updated: 2018-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-31

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine whether voice acoustic properties has an influence on sleep apnea. Sleep apnea syndrome is defined as a sudden stop of more than ten seconds multiple times during sleep. The syndrome is common especially among men and occurs in 2%-4% of the population aged 30-60. The syndrome diagnosis is performed by an ENT (Ear, Nose and Throat) physician. The diagnosis is based on evaluation of anatomical structures in the sound path (nose and throat, jaw, pharynx and oral cavity) and a Polysomnography (PSG) test which quantifies the number and duration of breathing pauses during night sleep and additional parameters that monitor sleep. The syndrome has many negative consequences for those who suffer from it, including fatigue , lack of concentration, hypertension, diabetes ,heart disease, stroke and even death. Therefore, early diagnosis is important.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea of Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

30 men suffering from apnea

Patients suffering from Sleep apnea

Intervention Type DIAGNOSTIC_TEST

PSG test

15 men defined as snorers

Patients suffering from Sleep apnea

Intervention Type DIAGNOSTIC_TEST

PSG test

15 men without complaints

Patients suffering from Sleep apnea

Intervention Type DIAGNOSTIC_TEST

PSG test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients suffering from Sleep apnea

PSG test

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and older men who meet the criteria for disorders such as apnea.
* 18 years old men and older who meet the criteria of snores based on screening questionnaires.
* 18 years old men and older who don't suffer from disorders such as apnea and do not suffer from snoring.

Exclusion Criteria

* Smoking Patients or smoked in the past.
* Having neurological disorders.
* Having swallowing trouble.
* Having Respiratory problems.
* Having Neuroendocrine problems.
* Having Voice disorders.
* Patients who were previously head or/and neck operated
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hillel Yaffe Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Itzhak Braverman, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Beata Greenberg, B.sc Biology

Role: CONTACT

0545355084 ext. +972

Adi Klein, M.A

Role: CONTACT

0522147213 ext. +972

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0019-18-HYMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Taiwan OSA Study
NCT07302685 RECRUITING